Correlation Between Tcr2 Therapeutics and Leap Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Leap Therapeutics, you can compare the effects of market volatilities on Tcr2 Therapeutics and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Leap Therapeutics.

Diversification Opportunities for Tcr2 Therapeutics and Leap Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tcr2 and Leap is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Leap Therapeutics go up and down completely randomly.

Pair Corralation between Tcr2 Therapeutics and Leap Therapeutics

If you would invest (100.00) in Tcr2 Therapeutics on November 29, 2024 and sell it today you would earn a total of  100.00  from holding Tcr2 Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Tcr2 Therapeutics  vs.  Leap Therapeutics

 Performance 
       Timeline  
Tcr2 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Leap Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Leap Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tcr2 Therapeutics and Leap Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tcr2 Therapeutics and Leap Therapeutics

The main advantage of trading using opposite Tcr2 Therapeutics and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.
The idea behind Tcr2 Therapeutics and Leap Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios